Antag Therapeutics News and Activities

View the org chart displaying its 16 main executives

Most searched biographies at Antag Therapeutics

• Joerg Moeller, Chief Executive Officer
• Jørgen Søberg, Non-Executive Director
• Philip Just Larsen, Chairman of the Board

Popular executive movements at Antag Therapeutics

• Imke Tiessen has joined the company as Chief of Staff  (posted on April 25 2025).
• Jens Norrild has joined the company as Vice President, Head of Chemistry, Manufacturing and Controls  (posted on April 25 2025).
• Alexander Sparre-Ulrich who was Chief Executive Officer, becomes Chief Operating Officer  (posted on January 8 2025).

Click here to view some more movements at Antag Therapeutics

Create your alert
to follow the executive moves at Antag Therapeutics.

Antag Therapeutics has 2,340 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).
• The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Antag Therapeutics

• Antag Therapeutics
• Antag Therapeutics appoints Dr. Christine T. Fischette to its Board of Directors

Social media about Antag Therapeutics

• Antag Therapeutics on Wikipedia, Google News & Yahoo Finance
• Antag Therapeutics on LinkedIn, Twitter & YouTube